BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2499109)

  • 1. Immunocytochemical demonstration of IGF-II-like immunoreactivity in human paraganglioma of the craniocervical region.
    Suzuki T; Iwafuchi M; Takahashi H; Ikuta F; Nishikawa K; Tanaka H; Yanaihara N
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):515-21. PubMed ID: 2499109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical demonstration of IGF-II immunoreactivity in human phaeochromocytoma and extra-adrenal abdominal paraganglioma.
    Suzuki T; Watanabe K; Sugino T; Tanigawa T; Satoh S
    J Pathol; 1992 Jun; 167(2):199-203. PubMed ID: 1635001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells.
    Kontogeorgos G; Scheithauer BW; Kovacs K; Horvath E; Melmed S
    Endocr Pathol; 2002; 13(3):197-206. PubMed ID: 12446918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial catecholamine secreting paragangliomas.
    Nelson MD; Kendall BE
    Neuroradiology; 1987; 29(3):277-82. PubMed ID: 3039399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functioning catecholamine-secreting vagal body tumor. A case report and review of the literature.
    Tannir NM; Cortas N; Allam C
    Cancer; 1983 Sep; 52(5):932-5. PubMed ID: 6347360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CHEMODECTOMAS OF THE CAROTID BODY AND GLOMUS JUGULARE].
    ARGONZ VE; MON AB
    An Cir (Rosario); 1964; 29():101-9. PubMed ID: 14291408
    [No Abstract]   [Full Text] [Related]  

  • 7. Paragangliomas of the craniocervical region. An immunohistochemical study on tyrosine hydroxylase.
    Takahashi H; Nakashima S; Kumanishi T; Ikuta F
    Acta Neuropathol; 1987; 73(3):227-32. PubMed ID: 2887082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors.
    Li SL; Goko H; Xu ZD; Kimura G; Sun Y; Kawachi MH; Wilson TG; Wilczynski S; Fujita-Yamaguchi Y
    Cell Tissue Res; 1998 Mar; 291(3):469-79. PubMed ID: 9477303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial paraganglioma.
    Işik AC; Erem C; Imamoğlu M; Cinel A; Sari A; Maral G
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):23-31. PubMed ID: 16320027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catecholamine metabolism in neck neoplasms].
    Bassalyk LS; Falileev GV; Gromova NV; Dzhumaev MG
    Sov Med; 1986; (11):22-7. PubMed ID: 3563670
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemodectomas (nonchromaffin paragangliomas) of the glomus jugulare, glomus vagale and carotid body.
    Weber AL; Davis KR; Nadol JB
    Ann Otol Rhinol Laryngol; 1982; 91(6 Pt 1):666-9. PubMed ID: 6293367
    [No Abstract]   [Full Text] [Related]  

  • 12. Paragangliomas of the head and neck region: a clinical study of 69 patients.
    Lack EE; Cubilla AL; Woodruff JM; Farr HW
    Cancer; 1977 Feb; 39(2):397-409. PubMed ID: 837327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-II-like immunoreactivity in human tissues, neuroendocrine tumors, and PC12 cells.
    Suzuki T; Iwafuchi M; Yanaihara C; Hatanaka H; Tao Z; Yanaihara N; Tanaka H; Nishikawa K
    Diabetes Res Clin Pract; 1989; 7 Suppl 1():S21-7. PubMed ID: 2680364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution to the tumors of the glomus caroticum and the glomus jugulare-tympanicum: clinical aspects, diagnosis, therapy].
    ROSE KG; BUTTENBERG H
    Z Laryngol Rhinol Otol; 1963 Apr; 42():240-53. PubMed ID: 13974797
    [No Abstract]   [Full Text] [Related]  

  • 15. Carotid body tumors, inheritance, and a high incidence of associated cervical paragangliomas.
    Gardner P; Dalsing M; Weisberger E; Sawchuk A; Miyamoto R
    Am J Surg; 1996 Aug; 172(2):196-9. PubMed ID: 8795531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy in glomus tumours (paragangliomas). A 25 year-review.
    Hansen HS; Thomsen KA
    Acta Otolaryngol Suppl; 1988; 449():151-4. PubMed ID: 2849282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism.
    Douwes Dekker PB; Kuipers-Dijkshoorn NJ; Baelde HJ; van der Mey AG; Hogendoorn PC; Cornelisse CJ
    Hum Pathol; 2007 Jan; 38(1):79-85. PubMed ID: 16949906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
    Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
    J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three kinds of chemodectoma in one patient--a rare case].
    Szyfter W; Kawczyński M
    Otolaryngol Pol; 2005; 59(1):115-8. PubMed ID: 15915930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagal body tumor (nonchromaffin paraganglioma, chemodectoma, and carotid body-like tumor) with cervical node metastasis and familial association: ultrastructural study and review.
    Kahn LB
    Cancer; 1976 Dec; 38(6):2367-77. PubMed ID: 187317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.